The CIDP Journey is a multifaceted exploration of chronic inflammatory demyelinating polyneuropathy and its impact on health care professionals, patients, research, therapy, finances, and policy. Join us as we examine the latest advances and controversies in the diagnosis and treatment of CIDP, the identification and use of biomarkers to guide diagnosis and treatment decisions, and the experiences of patients and health care professionals managing this challenging disease.

The CIDP Journey is associated with Clinical Neurology News, the source for timely, relevant, evidence-based, practice-changing information for neurologists. Readily accessible, interactive formats make Clinical Neurology News the best way for busy specialists to stay up to date and gain the perspectives they need to provide state-of-the-art care that improves patient outcomes.

Clinical Neurology News (www.mdedge.com/clinicalneurologynews) is owned by Frontline Medical Communications.

About Frontline Medical Communications
Frontline Medical Communications (Frontline) serves more than 1.2 million physicians and other health care professionals with diverse print and interactive multimedia products and platforms, and live events.

More than 30 enduring specialty journal brands offer a powerful synergy, including indexed, clinical, practical, and daily news content in the following fields:

• allergy
• cardiology
• dermatology
• emergency medicine
• endocrinology/diabetology
• family medicine
• federal clinical medicine
• gastroenterology
• geriatrics
• internal medicine
• neurology
• nurse practitioners
• physician assistants
• obstetrics/gynecology
• oncology/hematology
• orthopedic surgery
• pain medicine
• pediatrics
• primary care
• psychiatry
• pulmonology
• rheumatology
• general surgery
• vascular surgery.